The U.S. Federal Trade Commission on Tuesday said it seeks to unwind life science company Illumina Inc’s $7.1 billion acquisition of Grail Inc, alleging it would harm innovation and boost prices. FTC senior counsel...
Pfizer to buy cancer drug developer Trillium in $2.3 bln deal
Pfizer Inc said on Monday it would buy Canadian drug developer Trillium Therapeutics Inc in a $2.26 billion deal to strengthen its arsenal of blood cancer therapies. Pfizer, which acquired a $25 million stake in...
Serum Institute buys 50% stake in packaging JV SCHOTT Kaisha
Serum Institute of India, the largest vaccine producer and manufacturer of biologics, has bought the 50% stake in the Indian packaging joint venture SCHOTT Kaisha from former co-owners Kairus Dadachanji and Shapoor...
Aurobindo Pharma to buy US animal health firm Cronus for Rs 420 cr
Aurobindo Pharma has agreed to invest Rs 420 crore to buy upto 51 percent stake in Cronus Pharma Specialties aiming to tap global animal health generics space. Hyderabad-based Cronus is engaged in development...
PI Industries to acquire API biz from Ind-Swift Labs
Ind-Swift Laboratories has agreed to sell its Active Pharmaceuticals Ingredients (API) business to PI Industries on a slump sale basis, both the companies said in exchange notifications. The business transfer agreement...
Sanofi India sells nutraceuticals biz to Kedaara-Universal Medicare for ₹587 cr
Sanofi India Ltd on Wednesday said its board has approved the sale and transfer of its nutraceuticals business to Universal Nutriscience Pvt. Ltd for ₹587 crore. The move will help Sanofi India focus strongly on its...
Insud Pharma to sell stake in biotech unit mAbxience – sources
Spain’s Insud Pharma plans to sell a stake in its biopharmaceuticals unit mAbxience in a deal that is expected to value the maker of monoclonal antibodies at about 1 billion euros ($1.18 billion), people close to the...
Global private equity funds in talks to purchase minority stake in BDR Pharmaceuticals
Several global funds are in early stages of discussions to acquire a minority stake in BDR Pharmaceuticals, a mid-size drug manufacturer which has been in the limelight since the start of the Covid-19 pandemic...
PAG to acquire contact manufacturer Acme Formulation
PAG, a leading Asia-focused private equity firm, has acquired a controlling stake in Acme Formulation, a leading contract development and manufacturing outsourcing (CDMO) company with a focus on complex pharmaceutical...
German Pharma-Park Marburg, home to BioNTech, up for sale -sources
Pharma-Park Marburg, where German drugmaker BioNTech produces its COVID-19 vaccine, has been put up for sale in a potential 450 million euro ($531 million) deal, three people close to the matter said. The biotech...
Partners Group acquires generics drugmaker Pharmathen
Swiss-based Partners Group has agreed to acquire European pharmaceuticals company Pharmathen in a deal valuing the business at an enterprise value of about 1.6 billion euros ($1.36 billion), the investment company said...
Piramal Pharma completes acquisition of Hemmo Pharmaceuticals
Piramal Enterprises on Wednesday said its subsidiary, Piramal Pharma, has completed the acquisition of Hemmo Pharmaceuticals. “Piramal Pharma Ltd has completed the acquisition of Hemmo,” Piramal Enterprises...
